Corcept Therapeutics Incorporated capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.02x
Net debt / equity: -0.16x
Debt / assets: 0.01x
Debt / EBITDA: 0.68x
Net debt / EBITDA: -7.00x

Liquidity & coverage

Current ratio: 2.86x
Quick ratio: 2.77x
Cash ratio: 2.27x
Interest coverage: —
EBITDA / interest: —
Working capital: $276.8M

Cash & dividend

FCF / debt: 12.43x
Cash flow / debt: 12.46x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.